These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 279227)

  • 21. [Electrophysiological study of the mexiletine (author's transl)].
    Ebagosti A; Lodovici F; Escojido H; Torresani J; Jouve A
    Ann Cardiol Angeiol (Paris); 1979; 28(3):181-8. PubMed ID: 507723
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of mexiletine on the electrophysical properties of the intact human heart.
    Harper RW; Olsson SB; Varnauskas E
    Scand J Clin Lab Invest; 1977 Oct; 37(6):503-7. PubMed ID: 616069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of mexiletine on left ventricular ejection: a comparison with lignocaine and propranolol.
    Shaw TR
    Postgrad Med J; 1977; 53 Suppl 1():69-73. PubMed ID: 876955
    [No Abstract]   [Full Text] [Related]  

  • 24. Mexiletine action on the specialized tissues of the human heart.
    Pozzoni L; Romano S; Beltrami A; Calosso E; Verzoni A; Longoni A; Croce L
    Int J Clin Pharmacol Res; 1985; 5(4):229-36. PubMed ID: 4055166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical.
    Heath BM; Cui Y; Worton S; Lawton B; Ward G; Ballini E; Doe CP; Ellis C; Patel BA; McMahon NC
    J Pharmacol Toxicol Methods; 2011; 63(3):258-68. PubMed ID: 21194571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological effects of mexiletine in man.
    Roos JC; Paalman AC; Dunning AJ
    Br Heart J; 1976 Dec; 38(12):1262-71. PubMed ID: 1008969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
    Costard-Jäckle A; Franz MR
    J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mexiletine in isolated tissue models.
    Williams EM
    Postgrad Med J; 1977; 53 Suppl 1():30-4. PubMed ID: 876951
    [No Abstract]   [Full Text] [Related]  

  • 29. Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.
    Arita M; Goto M; Nagamoto Y; Saikawa T
    Br J Pharmacol; 1979 Sep; 67(1):143-52. PubMed ID: 497518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proceedings: Comparison of the effects of mexiletine, lignocaine and procainamide on canine Purkinje fibres.
    Allen JD; Arnold JM
    J Physiol; 1974 Jan; 236(1):26P-28P. PubMed ID: 4818502
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of oral mexiletine on left and right ventricular function.
    Stein J; Podrid P; Lown B
    Am J Cardiol; 1984 Sep; 54(6):575-8. PubMed ID: 6475776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental studies on the antiarrhythmic mechanism of mexiletine in guinea pig ventricular muscles using microelectrode techniques].
    Matsuo S
    Nihon Ika Daigaku Zasshi; 1984 Apr; 51(2):208-23. PubMed ID: 6330160
    [No Abstract]   [Full Text] [Related]  

  • 33. Arrhythmogenic effects of mexiletine in infarcted Purkinje tissues.
    Han J; Derhsam GH; O'Connell DP
    J Electrocardiol; 1989 Jan; 22(1):81-7. PubMed ID: 2921581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of mexiletine on action potential duration and its restitution in guinea pig ventricular muscles.
    Matsuo S; Kishida H; Munakata K; Atarashi H
    Jpn Heart J; 1985 Mar; 26(2):271-87. PubMed ID: 4009969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the effect of Melixetin (Kö 1173) on AV-conduction time and sinus pulse automation in persons with healthy hearts and in patients with disorders of the impulse-conduction system].
    Lang KF; Just H; Limbourg P
    Z Kardiol; 1975 May; 64(5):389-95. PubMed ID: 1189534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodynamic and electrophysiological effects of intravenous injection of mexiletine].
    Tanaka T; Kusumoto M; Umemura J; Miyazawa Y; Suwa J; Komatsu Y
    Kokyu To Junkan; 1983 Dec; 31(12):1355-60. PubMed ID: 6676806
    [No Abstract]   [Full Text] [Related]  

  • 37. Electrophysiological actions of mexiletine on rabbit sinoatrial node cells.
    Igawa O; Kotake H; Mashiba H
    Eur J Pharmacol; 1986 Mar; 122(1):11-7. PubMed ID: 3956576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide.
    Campbell TJ
    J Cardiovasc Pharmacol; 1983; 5(2):291-6. PubMed ID: 6188905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockage of the sodium current in isolated single cells from rat ventricle with mexiletine and disopyramide.
    Yatani A; Akaike N
    J Mol Cell Cardiol; 1985 May; 17(5):467-76. PubMed ID: 2411942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of mexiletine on transmembrane action potentials as affected by external potassium concentration and by rate of stimulation in guinea-pig papillary muscles.
    Sada H; Ban T; Oshita S
    Clin Exp Pharmacol Physiol; 1980 Nov; 7(6):583-93. PubMed ID: 7249399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.